Skip to main content
. 2023 May 5;15(5):e38604. doi: 10.7759/cureus.38604

Table 1. Baseline demographics of participating women after propensity score matching.

Each date shows average ± standard deviation. *: Significant difference between the two groups.

YSM: years since menopause (years); BMI: body mass index (kg/m2); DM: diabetes mellitus; HT: hypertension; VEL: vaginal erbium SMOOTH mode laser treatment; VEL+Nd:YAG: VEL and neodymium-doped yttrium-aluminum-garnet laser combination treatment

  VEL+Nd:YAG group VEL group P-value*
Number of women 102 102
Age (years) 59.83 ± 1.41 59.94 ± 1.41 0.586
Age at menopause (years) 48.83 ± 2.01 49.00 ± 1.86 0.539
YSM 11.00 ± 1.40 10.94 ± 1.39 0.764
BMI 22.91 ± 2.51 22.68 ± 2.74 0.523
The proportion of DM women (%) 8 ± 7.8 7 ± 6.9 1.00
The proportion of HT women (%) 10 ± 9.8 11 ± 10.8 1.00
The proportion of smokers (%) 5 ± 4.9 6 ± 5.9 1.00
Follow-up period (years) 2.50 ± 0.51 2.53 ± 0.54 0.750